6
MERK0206.TXT

MERK
Merck Indonesia Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Jun-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 6

Summary of Balance Sheet
  Receivables               :      54,252,613.00
  Inventories               :      42,732,842.00
  Current Assets            :     134,118,774.00
  Fixed Assets              :      14,126,110.00
  Other Asstes              :       7,979,594.00
  Total Assets              :     166,740,376.00
  Current Liabilities       :      25,458,738.00
  Longterm Liabiities       :               0.00
  Total Liabilities         :      25,458,738.00
  Authorized                :          22,400.00
  Paid-up Capital           :      22,400,000.00
  Par Value                 :               1000
  Paid-up Capital Shares    :          22,400.00
  Retained Earnings         :     100,017,386.00
  Total Equity              :     141,281,638.00
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :     116,184,079.00
  Cost of Good Sold         :      47,007,391.00
  Gross Profit              :      69,176,688.00
  Operating Profit          :      32,216,195.00
  Other Income              :         318,883.00
  Eearning Before Tax       :      32,535,078.00
  Tax                       :       9,787,449.00
  Net Income                :      22,747,629.00
  Closing Price             :          15,000.00

Per Share Data (Rp)
  Eps                       :           2,031.04
  Book Value                :           6,307.22

Financial Ratios
  Debt Equity Ratio (X)     :                .18
  Roa (%)                   :              27.29
  Roe (%)                   :              32.20
  Npm (%)                   :              19.58
  Opm (%)                   :              27.73

Cash Flow
  CF from Operating Activities                        :      -3,430,268.00
  CF from Investing Activities                        :      -1,286,885.00
  CF from Financing Activities                        :               0.00
  Net Increase in Cash & Cash Equivalent              :      -4,717,153.00
  Cash & Cash Equivalent at The Beginning of The Year :      34,013,078.00
  Cash & Cash Equivalent at The End of The Year       :      29,295,925.00

 
 
 
